Tutorials › CAS Exam 8 - Advanced Ratemaking › Rate Regulation Standards and Filing Pathways

CAS Exam 8 · Rate Regulation and Filings · Tutorial 891 of 989

Rate Regulation Standards and Filing Pathways

Learn how regulatory pathways change when rates may be implemented and what actuarial support helps demonstrate that proposed rates meet applicable standards.

Intermediate 11 min read

What You'll Learn

  • Distinguish prior-approval, file-and-use, and use-and-file requirements.
  • Explain how competitive rating systems differ without assuming regulation disappears.
  • Relate rate support to adequacy, excessiveness, reasonableness, and fair discrimination.
  • Calculate an indicated rate when profit is expressed as a share of premium.
  • Identify how a filing pathway affects the evidence and timing needed to support a rate change.

Why Rate Regulation Changes the Ratemaking Decision

A rate recommendation and permission to use that rate are different things. An actuarial indication may suggest that a change is needed, but the applicable regulatory system determines when a proposed rate can be implemented and what review may occur before or after use. The governing requirements depend on the jurisdiction, line of insurance, and applicable law; the labels used for filing pathways do not, by themselves, establish one universal process.

For an actuary, the practical question is not simply whether a proposed rate is numerically supported. The support must also address the standards that apply and be presented through the required pathway. A well-supported indication can still require revision, additional explanation, or regulatory approval before it may be used.

Definition: A rate filing pathway specifies when and how an insurer must submit proposed rates to the regulator, and whether regulatory review or approval is required before the rates may be used. A rate standard is a statutory or regulatory criterion that rates must satisfy. The precise pathway and standards vary by jurisdiction and line of insurance.

Common Filing Pathways

The four broad systems below describe different relationships between filing, regulatory review, and implementation. Actual statutes may modify these features, set different deadlines, or use other terms. An actuary must confirm the rules that apply rather than infer them from a pathway’s name.

PathwayGeneral timingRegulatory reviewKey practical implication
Prior approvalRates generally may not be used until approval is granted.Review occurs before use; the regulator may request support or changes.Implementation depends on the approval process and its timing.
File-and-useThe insurer files first and may use the rates after any applicable waiting period or other condition.Review may occur before or after implementation, depending on the rules.The filing date, waiting period, and any restriction on use matter.
Use-and-fileThe insurer may use the rates before filing, but must submit them within the required period.Review generally follows implementation.Post-use review can still lead to questions or required changes.
Competitive ratingRates may be set with less or no routine prior approval where the applicable system permits it.Regulatory oversight may still apply, including through other standards or review powers.“Competitive” does not mean “unregulated” or exempt from all legal requirements.

These pathways differ most visibly in the timing of use, but that timing can affect planning and business decisions. Under prior approval, a proposed effective date cannot be treated as certain until the required approval is obtained. Under a file-and-use system, a waiting period or other condition may delay use even when a filing has been submitted. Under use-and-file, early implementation shifts some review to a later point; it does not eliminate the possibility of scrutiny.

A competitive rating system generally gives insurers greater freedom to respond to market conditions. However, the extent of that freedom is jurisdiction-specific. Statutory standards, restrictions on unfair discrimination, filing obligations, or regulatory examination may continue to apply. The responsible conclusion is therefore based on the governing rules, not on the label “competitive.”

Worked Example: Comparing Implementation Dates Under Hypothetical Rules

A hypothetical jurisdiction has three rules for a line of business: prior-approval rates cannot be used before written approval; file-and-use rates may be used 30 calendar days after filing unless use is prohibited sooner; and use-and-file rates may be implemented immediately but must be filed within 10 calendar days. An insurer proposes an 8% increase to a base annual premium of $750. It files under prior approval and file-and-use on October 2, and receives written approval on November 12. For a separate use-and-file proposal, it implements the same increase on November 1. Determine the earliest use dates and the revised premium in each case.

Method. Apply each hypothetical rule separately; do not assume that submission alone authorizes use.

Prior approval. The insurer cannot use the proposed rate before written approval. Approval arrives on November 12, so the earliest use date under the stated rule is November 12.

File-and-use. The filing is made on October 2. Thirty calendar days later is November 1. Because the hypothetical rule permits use after that period unless use is prohibited sooner, the earliest use date is November 1, subject to that condition.

Use-and-file. The insurer implements the change on November 1. The filing is due within 10 calendar days under the stated rule, so the insurer must meet the November 11 deadline. The exact counting convention must be confirmed under the applicable rules; this example treats the 10 calendar days after November 1 as ending November 11.

Premium calculation. An 8% increase means multiplying the base premium by 1.08:

$$ 750(1.08)=810 $$

The revised annual premium is $810.00 under each pathway once the increase may be used. The pathways change the earliest implementation timing and filing obligation, not the arithmetic of the increase.

Check. The increase is $810.00 − $750.00 = $60.00, and $60.00 / $750.00 = 0.08. A common mistake is to treat a filed rate as automatically usable under prior approval; the correction is to wait for the required written approval.

What the Rate Standards Ask

Statutory wording differs, but several concepts recur. Rates commonly must be adequate, not excessive, and not unfairly discriminatory. Some laws or regulatory frameworks also use reasonableness language. These concepts are related, but they ask different questions and should not be treated as interchangeable.

Definition: Adequacy concerns whether rates are sufficient, in the aggregate or as otherwise required by law, to cover expected losses and expenses and support the insurer’s financial obligations. Excessiveness concerns whether rates are unreasonably high in relation to the benefits and risks insured or other applicable criteria. Unfair discrimination concerns differences in rates or rating treatment that are not appropriately justified by relevant risk or cost differences. The statutory test and the meaning of reasonableness must be read in their legal context.

Adequacy does not mean that every individual policy will produce enough premium to match its realized losses. Insurance costs are uncertain, and rates are prospective estimates. The standard is applied under the governing law and to the relevant rate level, classifications, or other unit of review. Likewise, a difference between two customers’ rates is not automatically unfair discrimination. A difference may be actuarially supportable if it reflects relevant differences in expected cost and is permitted by law.

A filing’s actuarial support should make the reasoning reviewable. Depending on the requirements, that support may explain the proposed rate level, the basis for key assumptions, how the proposal affects customers or classes, and why rating differences are justified. The detail required is not identical everywhere. The central discipline is to connect the proposed rates to evidence and to the applicable standards, rather than relying only on a statement that the rates are “indicated.”

A Rate Indication and Its Regulatory Meaning

A simple rate indication can illustrate how a target profit provision enters a proposed rate. Suppose \(L\) is expected loss and loss adjustment expense per exposure, \(E\) is all other fixed expense provision per exposure, \(R\) is the indicated rate per exposure, and \(q\) is a target profit provision expressed as a fraction of premium. Under this simplified model, the premium must fund expected losses, expenses, and the profit provision.

$$ R=L+E+qR $$

The profit term is \(qR\), not \(q\) dollars per exposure, because the assumption defines profit as a share of premium. Rearranging gives the indicated rate:

$$ R(1-q)=L+E \qquad\Longrightarrow\qquad R=\frac{L+E}{1-q} $$

This derivation assumes a single rate per exposure, loss and expense provisions that are fixed dollar amounts per exposure, and a profit provision equal to a fixed fraction \(q\) of premium, with \(q<1\). It does not directly apply if expenses are also expressed as a percentage of premium, if there are multiple coverage-specific provisions, or if the applicable methodology defines the profit provision differently. In those cases, the equation must reflect those terms explicitly.

Worked Example: Relating an Indication to an Adequacy Question

A hypothetical insurer estimates annual expected loss and loss adjustment expense of $310 per exposure and a fixed expense provision of $105 per exposure for a coverage. Its target profit provision is 5% of premium. The current annual rate is $500 per exposure. Under the simplified model above, calculate the indicated rate and its percentage change from the current rate. Then explain what the calculation does and does not establish about regulatory standards.

Method. Because the profit provision is a percentage of premium, solve for the rate using \(R=(L+E)/(1-q)\).

First add the per-exposure loss and expense provisions:

$$ L+E=310+105=415 $$

The profit proportion is \(q=0.05\), so:

$$ R=\frac{415}{1-0.05} =\frac{415}{0.95} =436.842105\ldots $$

Rounded to the nearest cent, the indicated rate is $436.84 per exposure. The percentage change from the current rate is:

$$ \frac{436.842105\ldots-500}{500} =-0.126315789\ldots $$

Rounded to two decimal places as a percentage, the indication is a 12.63% decrease. The result is a modeled indication under the stated assumptions. It does not, by itself, prove that the proposed rate is legally adequate, not excessive, reasonable, or approved. That conclusion also depends on the applicable standards, the support required for the filing, and any relevant review.

Check. At the unrounded indicated rate, the modeled components sum to the rate: \(310+105+0.05(436.842105\ldots)=436.842105\ldots\). A common error is to add 5% of the loss-and-expense amount, producing \(415(1.05)=435.75\). That uses profit as a markup on cost, not as 5% of premium. The correction is to solve \(R=415+0.05R\), which gives \(R=436.84\) when rounded to cents.

Classification Support and Competitive Systems

Rate standards also shape how an insurer supports classification differences. The question is not whether two classes have different rates, but whether the differences follow a permissible and supportable basis. An indicated relativity can be affected by expenses and profit provisions as well as by expected losses. A regulator may also consider whether the classifications and rating factors comply with the applicable law.

In a competitive system, market forces may influence the prices an insurer chooses, but they do not make actuarial reasoning irrelevant. A rate change may affect adequacy, customer impacts, and consistency with legal restrictions. Moreover, a difference that appears commercially useful is not automatically acceptable if it lacks a permissible rating basis.

Worked Example: Testing Whether Class Rates Reflect the Stated Basis

A hypothetical insurer has two coverage classes with the same contract terms. Its prospective annual expected loss and loss adjustment expense are $420 per exposure for Class A and $600 for Class B. Each class has a fixed expense provision of $80 per exposure and a profit provision of 5% of premium. A proposed rating factor produces rates of $526.32 and $715.79, respectively. Calculate the indicated rates and compare the proposed difference with the expected-cost basis. State what the arithmetic can establish about fair classification.

Method. Apply the same stated rate formula to each class. Round final rates to cents.

For Class A:

$$ R_A=\frac{420+80}{1-0.05} =\frac{500}{0.95} =526.315789\ldots $$

Thus the Class A indicated rate is $526.32. For Class B:

$$ R_B=\frac{600+80}{1-0.05} =\frac{680}{0.95} =715.789473\ldots $$

Thus the Class B indicated rate is $715.79. The indicated rate ratio is:

$$ \frac{R_B}{R_A} =\frac{680/0.95}{500/0.95} =\frac{680}{500} =1.36 $$

The expected loss and loss adjustment expense ratio is \(600/420=1.428571\ldots\), but the indicated gross rate ratio is 1.36. The fixed $80 expense provision is the same for both classes, so it reduces the relative difference between their total indicated costs. The proposed rates match the indicated rates to the nearest cent.

Conclusion and check. The arithmetic supports the proposed rate difference under the simplified assumptions: the indicated difference is $715.79 − $526.32 = $189.47. This calculation alone does not establish that the classification is legally permissible or that the underlying expected costs are adequately supported. A common mistake is to apply the loss-cost ratio of 1.4286 directly to the gross Class A rate; that ignores the equal fixed expense provision. The correction is to calculate each class’s indicated rate from its full stated cost components.

Building a Defensible Regulatory Argument

The pathway determines when a rate may be used and when review may occur. The standards determine what the rate must satisfy. These are separate questions, and a sound actuarial explanation keeps them separate while connecting both to the proposed action.

1
Identify the applicable rule.
Confirm the jurisdiction, line, pathway, deadlines, and any conditions on implementation. Do not assume that a familiar pathway label settles the details.
2
State the actuarial basis.
Explain the rate indication and its assumptions clearly enough that a reviewer can understand how the proposed rates relate to expected costs and other provisions.
3
Address the relevant standards.
Connect the proposed rate level and any class differences to the applicable requirements, including adequacy, excessiveness, reasonableness, or unfair discrimination where relevant.
4
Separate calculation from conclusion.
A correct indication is evidence for a regulatory argument, not a substitute for the legal test or a guarantee of approval.

This distinction matters in practice. Treating an indication as automatic authorization can lead to premature use of rates under a prior-approval system. Treating competitive rating as an absence of oversight can overlook continuing statutory limits. Conversely, assuming that any difference between classes is unfair ignores the possibility that relevant, supportable risk differences justify different rates. The disciplined approach is to verify the pathway, apply the appropriate actuarial method, and make the connection to the governing standards explicit.

Key takeaway: A filing pathway governs the timing and process of rate use; rate standards govern whether the proposed rates are acceptable. Actuarial calculations support the analysis, but neither a filing nor an indication alone establishes compliance.

Check Your Understanding

For each hypothetical situation, identify the relevant calculation or regulatory distinction.

  1. A hypothetical jurisdiction allows file-and-use rates 20 calendar days after filing unless use is prohibited sooner. An insurer files on April 3. What is the earliest use date under the stated rule, assuming no earlier prohibition? (Answer: April 23.)
  2. An insurer has expected loss and loss adjustment expense of $360 per exposure, fixed expenses of $90 per exposure, and a profit provision equal to 4% of premium. Find the indicated rate and the percentage change from a current rate of $500. Round the rate to cents and the percentage to two decimal places. (Answer: $468.75; a 6.25% decrease.)
  3. Two classes have expected loss and loss adjustment expense of $290 and $410 per exposure. Each has fixed expenses of $70, and each uses a 5% profit provision as a share of premium. Calculate the indicated rate for each class and the ratio of the second rate to the first. Round rates to cents and the ratio to four decimal places. (Answer: $378.95 and $505.26; ratio 1.3333.)
  4. In a hypothetical use-and-file system, an insurer implements a rate change before filing and is later asked to justify a class differential. Does the ability to use the rate before filing establish that the differential is acceptable? State what must still be considered. (Answer: No. Post-use review may still apply, and the insurer must support the differential under the applicable standards and legal requirements.)
Clinical Biostats